MaxCyte, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-8.9M | $-4.8M | $-9.6M | $-12.4M | $-12.4M | $-10.3M | $-10.6M | $-11.6M |
| Depreciation & Amortization | $953.0K | $1.0M | $1.1M | $1.0M | $1.1M | $1.1M | $1.1M | $1.1M |
| Depreciation | $961.0K | $1.0M | $1.1M | $1.1M | $1.1M | $1.1M | — | $1.1M |
| Amortization | $17.0K | $17.0K | $16.0K | $15.0K | $12.0K | $10.0K | — | — |
| Stock-Based Compensation | $1.2M | $1.1M | $706.0K | $2.0M | $3.5M | $3.0M | $3.1M | $3.4M |
| Net Cash from Operating Activities | $-4.7M | $-8.2M | $-2.7M | $-7.5M | $-9.9M | $-14.4M | $-7.8M | $-4.4M |
| Investing Activities | ||||||||
| Capital Expenditures | $62.0K | $72.0K | $231.0K | $300.0K | $584.0K | $653.0K | $147.0K | $406.0K |
| Business Acquisitions | — | — | $0 | $0 | $0 | $1.8M | — | — |
| Net Cash from Investing Activities | $6.6M | $2.7M | $9.7M | $5.2M | $1.5M | $9.5M | $-1.7M | $3.6M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-1.4M | $5.0K | $105.0K | $14.0K | $154.0K | $383.0K | $412.0K | $228.0K |
| Net Change in Cash | $485.0K | $-5.5M | $7.1M | $-2.3M | $-8.2M | $-4.5M | $-9.1M | $-555.0K |
| Free Cash Flow | $-4.7M | $-8.2M | $-2.9M | $-7.8M | $-10.4M | $-15.1M | $-8.0M | $-4.8M |